RxDoctor Payments Data

Pratik Patel, MD

Clinical Cardiac Electrophysiology · Munster, INNPI 1104082445

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Biosense Webster, Inc. at 28.2% of the total. 2025 is the largest year on record at $9,436, 5.2 times the $1,813 reported in 2019.

$27,144in general payments, 2019–2025

Across 337 payments — averaging $80.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$8K
  • Medtronic$5K
  • Boston Scientific$4K
  • Abbott$4K
  • Altathera Pharmaceuticals LLC$1K
  • Atricure, Inc.$968
  • plus $5K from 30 others
$11,807in research payments, 2019–2025

Across 2 payments — averaging $5903.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Impulse Dynamics (USA) Inc.$12K

What the payments were for

  • Consulting fees$3,68314%
  • Travel & lodging$8,44031%
  • Food & beverage$15,00455%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,144 in reported general payments places this provider in the 65th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$427,451
Medicare patients
1,462
Services billed
4,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban687$690,884
XareltoRivaroxaban140$116,491
EntrestoSacubitril/Valsartan42$46,138
MultaqDronedarone Hcl26$31,189
Dofetilide118$20,322
Amiodarone Hcl368$13,823
Flecainide Acetate238$13,740
Metoprolol Succinate736$6,847
Propafenone Hcl ErPropafenone Hcl19$4,107
SotalolSotalol Hcl212$3,866
BystolicNebivolol Hcl14$2,398
Dilt-XrDiltiazem Hcl69$2,012
Diltiazem 24hr Er (Xr)Diltiazem Hcl55$1,657
Propafenone Hcl22$658
Sotalol AfSotalol Hcl17$594

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$59$690,884687 claims
Johnson & JohnsonXarelto$161$116,491140 claims
NovartisEntresto$301$46,13842 claims
Sanofi-aventis U.S. LLCMultaq$22$31,18926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

Other clinical cardiac electrophysiology in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →